Abstract 1385: Molecular changes in breast tumors following bevacizumab-based treatment: Final analysis of a randomized neoadjuvant study of bevacizumab or placebo, followed by chemotherapy with or without bevacizumab, in patients with stage II or III breast cancer
Year: 2012
Type: conference-abstract
Source: Cancer Research
Authors: Sara A. Hurvitz, Priti Hegde, Linda Bosserman, Mary Ann Allison, Michael Thirlwell, Ru-Fang Yeh, Ling Fu, Maike Schmidt, Brian Leyland-Jones, Eleonor Quan, David Molthrop, John Barstis, David Park, Maccon Keane, Gargi Upadhyaya, Giribala Patel, Steven Applebaum, Judy Dering, Charles Ginther, Brad Adams, Daniel S. Chen, Dennis J. Slamon
Institutions: University of California, Los Angeles, Genentech
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2329335673